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Oocyte Apoptosis: Like Sand through an Hourglass
Yutaka Morita and Jonathan L. Tilly1
Vincent Center for Reproductive Biology, Department of Obstetrics and Gynecology,
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Although the study of germ cell death is arguably still in its infancy as a field, several recent breakthroughs have provided
the fodder for a story, replete with episodes of apparent mass cellular suicide if not murder, that will undoubtedly serve as
a research base for many laboratories over the next several years. Death is known to strike the male and female germlines
with roughly equal intensity, but the innate feature of male germ cells being self-renewing while those of the female are not
places the death of oocytes in a completely different light. Indeed, the functional life span of the female gonads is defined
in most species, including humans, by the size and rate of depletion of the precious endowment of oocytes enclosed within
follicles in the ovaries at birth. This continuous loss of oocytes throughout life, referred to by many as the female biological
clock, appears to be driven by a genetic program of cell death that is composed of players and pathways conserved from
worms to humans. It is on this genetic pathway, and the role of its constituent molecules in regulating female germ cell fate,
that this review will focus. Emphasis will be placed on those studies using genetic-null or transgenic models to explore the
functional requirement of proteins, such as Bcl-2 family members, Apaf-1, and caspases in vertebrates to CED-9, CED-4, and
CED-3 in Caenorhabditis elegans, in oocyte survival and death. Furthermore, hypotheses regarding the potential impact of
translating what is now known of the oocyte death pathway into new approaches for the clinical diagnosis and management
of female infertility and the menopause will be offered as a means to stimulate further research in this new and exciting
field. © 1999 Academic PressKey Words: germ cell; oocyte; apoptosis; cell death; Bcl-2; Bax; caspase; ovary; menopause.
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OOCYTES, AND THE FEMALE
BIOLOGICAL CLOCK
The hourglass. An old-fashioned but reliable device for
monitoring the passage of time. Once inverted, each grain
of sand flows through a narrow opening separating the
upper and lower reservoirs, seemingly by a random pro-
cess. However, in each hourglass the number of sand
grains is carefully calculated to provide 60 minutes of
time before the upper reservoir irreversibly (unless, of
course, inverted once again) empties its contents into the
lower portion of the timepiece. In many respects, female
germ cells can be considered analogous to grains of sand
within an hourglass in that the continuous trickle of
oocytes out of the initial endowment provided at birth inm
c
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female biological clock” (Fig. 1). Once the oocyte re-
erve has been exhausted, ovarian senescence, driving
hat is referred to as the menopause in women, rapidly
nsues. However, unlike the passage of sand through an
ourglass, the size of the oocyte reserve set forth at birth
in other words, the number of sand grains initially
eposited in the upper reservoir), as well as the rate of
ocyte loss from the ovaries throughout postnatal life (or,
ow quickly the sand passes from the upper to lower
eservoirs), can be modified with dramatic consequences
n the fertile life span and overall well-being of females
s they age (Fig. 1). Accordingly, this represents one of the
ajor themes to be evaluated herein.
Although depletion of the female germ cell reserve
hroughout life is in itself not a particularly novel con-
ept, the involvement of apoptosis and its regulatory
olecules in this process represents a relatively new and
ertainly very exciting research initiative. Much of the
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2 Morita and Tillywork reported over the past few years with respect to the
mechanisms underlying oocyte loss has stemmed from a
rapidly accumulating volume of data derived from assess-
ments of apoptosis in other model systems, including
powerful genetic studies of cell death in the Caenorhab-
ditis elegans hermaphrodite and Drosophila (Hengartner,
1996; McCall and Steller, 1997; Bergmann et al., 1998;
etzstein et al., 1998). These observations have collec-
ively provided a molecular map of a cell death program,
emarkably conserved through evolution, that now
erves to guide developmental and reproductive biolo-
ists in designing experiments necessary to delineate the
enetics and biochemistry of oocyte apoptosis. Moreover,
he recent availability of mice lacking key components of
his conserved cell death program has proved instrumen-
al for substantiating many correlative gene expression
tudies in that certain molecules have been identified as
ndispensable for female germ cell survival or for death to
roceed. This article will therefore attempt to summarize
ur current understanding of the events responsible for
nitiating oocyte apoptosis and will hypothesize how this
FIG. 1. Analogy drawn between the loss of oocytes via apoptosis
and the trickling of grains of sand through an hourglass to define
the female biological clock. In the upper reservoir, each grain of
sand can be considered a healthy oocyte. Just as the number of
grains of sand in the upper reservoir of an hourglass is calculated to
provide an hour of time before all of the sand passes to the lower
reservoir, the rate at which healthy oocytes pass irrevocably into
the apoptotic pool (due to prenatal germ cell attrition, postnatal
follicular atresia, or exposure of the ovary to pathologic insults)
defines how long the female biological clock will tick. Importantly,
the rate at which the healthy oocyte reserve is decimated by
apoptosis is precisely controlled by a number of molecules that
comprise an evolutionarily conserved cell death program (see Figs.
2 and 3).nformation may one day be used to alter the rate by
hich the female biological clock ticks.
Copyright © 1999 by Academic Press. All rightBIOCHEMISTRY AND GENETICS OF CELL
DEATH: HOW THE CLOCK TICKS?
As a preface for the discussions to come, this section will
briefly overview apoptosis and its constituent molecules
(for more in-depth reviews on this topic, the reader is
referred to Adams and Cory, 1998; Ashkenazi and Dixit,
1998; Green, 1998; Green and Reed, 1998; Minn et al., 1998;
Thornberry and Lazebnik, 1998; Vaux and Korsmeyer,
1999). In it most simplistic form, apoptosis can be broken
down into four stages, the first of which is receipt by the
cell of a potentially lethal stimulus (Fig. 2). These stimuli
come in many forms, both physiological and pathological.
In those instances of normal cell turnover, the two primary
inputs leading to apoptosis are active induction via expo-
sure to death-promoting members of the Fas ligand (also
referred to as CD95 or APO-1)/tumor necrosis factor-a
superfamily (Nagata, 1997; Ashkenazi and Dixit, 1998;
Peter and Krammer, 1998) or “death by neglect” resulting
from inadequate levels of key survival/growth factors (Raff,
1992; Conlon and Raff, 1999). Interestingly, many patho-
logical insults, such as cancer therapies (chemical and
radiation) and environmental toxicants, can also trigger
apoptosis (Eastman, 1993; Verheij et al., 1998), a concept
that has raised much attention in recent years and is of
particular relevance to the topic at hand (see “Premature
Ovarian Failure” below and Tilly, 1998a).
The second stage of apoptosis is the recruitment of early
intracellular signaling molecules that relay the plethora of
external information received by the cell to a central regula-
tory checkpoint for interpretation (i.e., the third stage) gov-
erned primarily by the Bcl-2 family of proteins (Fig. 2). The
second messengers utilized by each cell vary depending upon
the type and magnitude (dose and duration) of stimulus
received and include molecules derived from both gene ex-
pression (e.g., p53, Ko and Prives, 1996; Ding and Fisher, 1998;
kinases, Verheij et al., 1996; Datta et al., 1997; Kennedy et al.,
1997) and cellular metabolism (e.g., ceramide, Hannun, 1996;
Kolesnick and Kronke, 1998; sphingosine 1-phosphate, Spiegel
et al., 1998; reactive oxygen species, Hampton et al., 1998).
Integration of the information provided by these signals into a
final decision for cellular life or death is then made at the level
of the mitochondrion, the primary intracellular site of Bcl-2
family member localization and function (Green and Reed,
1998).
The bcl-2 protooncogene was first identified from the
chromosomal translocation event t(14;18)(q32;21), charac-
teristic of certain B-cell lymphomas, that juxtaposed the
immunoglobulin heavy chain enhancer/promoter adjacent
to the Bcl-2 coding sequence (Bakhshi et al., 1985; Cleary
and Sklar, 1985; Tsujimoto et al., 1985). The oncogenic
potential of Bcl-2 overexpression in this context was later
identified as being the result of the ability of the protein to
convey resistance to apoptosis in the face of growth factor
withdrawal (Vaux et al., 1988), a mechanism of action that
has since been enumerated many times over regardless of
s of reproduction in any form reserved.
; Cyt-c, cytochrome c; AIF, apoptosis-inducing factor; DFF45, DNA
3Oocyte Apoptosisthe initiating stimulus for cell death (Korsmeyer, 1998;
Reed, 1998). The vertebrate Bcl-2 family now consists of at
least 16 members (Adams and Cory, 1998; Korsmeyer, 1998;
Minn et al., 1998; Reed, 1998), subdivided as antiapoptotic
(e.g., Bcl-2, Bcl-xL, Mcl-1, A1, Bcl-w, NR-13) or proapoptotic
(e.g., Bax, Bcl-xS, Bad, Bak, Bid, Bik/Blk, Bim, Hrk, Bok/
Mtd), with one new member with expression almost re-
stricted to the ovary remaining controversial in terms of
function (Diva or Boo; Inohara et al., 1998; Song et al.,
1999).
The characterization of Bcl-2, the founding member of
the family, as a protein that for the most part functions to
prevent apoptosis provided the first link to a now well-
established genetic program of cell death conserved be-
tween invertebrate and vertebrate species (Fig. 3). The most
frequently studied model of cell death in invertebrates is
the C. elegans hermaphrodite, in which 131 of the 1090
somatic cells formed during development of the nematode
undergo programmed death (Ellis et al., 1986, 1991; Hen-
gartner, 1996; Metzstein et al., 1998). Inactivating muta-
tions in the ced-9 gene of C. elegans leads to massive cell
death and embryonic lethality (Hengartner, 1996;
FIG. 2. Schema of events that define four general stages of apopt
potentially lethal stimulus, which then activates one or more early
relayed into the central regulators at stage 3 for integration in wh
outcome, the fourth stage comprising the effector molecules requir
(Apaf-1) coupled to Bcl-2 family member function (mitochondrial st
not defined in the text: FasL, Fas ligand; TNFa, tumor necrosis facto
PKC, protein kinase C; SAPKs, stress-activated protein kinases
fragmentation factor-45; CAD, caspase-activated DNase.osis induction and execution. The first stage is receipt by the cell of a
signaling molecules during stage 2. These immediate-early signals are
ich the final decision for life or death is made. If apoptosis is to be the
ed to dismantle the cell is activated through a molecular bridge protein
ability and cytochrome c release) at stage 3. Abbreviations used that are
r-a; PI3K, phosphatidylinositol 39-kinase; S1P, sphingosine 1-phosphate;Metzstein et al., 1998), implying that the CED-9 protein
encodes a molecule similar to Bcl-2 with respect to func-
Copyright © 1999 by Academic Press. All rightFIG. 3. Evolutionary conservation of the cell death program from
worms to humans. Upon receipt by the cell of a lethal stimulus, the
intracellular death pathway is activated in both C. elegans (left) and
vertebrates (right) by suppression of CED-9/Bcl-2-like survival
function. This can occur either directly or indirectly via induction
of proapoptotic cytoplasmic signals (Egl-1/Hrk-like molecules) that
can antagonize CED-9/Bcl-2-like action. Once CED-9/Bcl-2-like
function is repressed, activation of CED-4/Apaf-1 occurs, leading to
induction of CED-3/caspases as final executioners of the cell death
program. Molecules in green boxes are antiapoptotic, whereas
those in red boxes are proapoptotic.
s of reproduction in any form reserved.
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4 Morita and Tillytion. Cloning of the ced-9 gene revealed significant struc-
ural similarity with bcl-2 as well (Hengartner and Horvitz,
1994), data further supported by the findings that Bcl-2 can
substitute for CED-9 to partially restore cellular survival in
ced-92/2 animals (Vaux et al., 1992). More recently, a
molecule somewhat analogous to proapoptotic members of
the Bcl-2 family containing only the BH3 domain (e.g., Hrk,
Bad, Bim, Bid), termed Egl-1, has emerged in C. elegans as a
negative regulator of CED-9 function (Conradt and Horvitz,
1998; del Peso et al., 1998), further establishing the simi-
larities in cell death regulation between invertebrates and
vertebrates (Fig. 3).
Many functions of Bcl-2 family members have been
ascribed over the years (Reed, 1994), but one mechanism in
particular, i.e., the pivotal role of mitochondria as integra-
tors of Bcl-2 family function as well as a source of proapop-
totic factors (Green and Reed, 1998), has gained the accep-
tance of many in the field as the principal means by which
these proteins probably regulate activation of the fourth and
final stage of apoptosis involving the effector or “execu-
tioner” molecules (Fig. 2). Several members of the Bcl-2
protein family exhibit subcellular localization to mitochon-
drial membranes (Hockenberry et al., 1990; Gonzalez-
Garcia et al., 1994; Wang and Studzinski, 1997; Hegde et al.,
1998; Motoyama et al., 1998), and in the case of Bax, this
proapoptotic molecule translocates from the cytosol to
mitochondria upon exposure of the cell to an apoptotic
stimulus (Wolter et al., 1997; Gross et al., 1998). A similar
cytosolic-to-mitochondrial relocalization has been de-
scribed for the proapoptotic protein Bid, although cleavage
of Bid to a truncated form is required for its mitochondrial
insertion (Gross et al., 1999). Parallel studies published 2
years ago (Kluck et al., 1997; Yang et al., 1997) demon-
strated that Bcl-2 directly blocks mitochondrial cyto-
chrome c release and the subsequent activation of caspases
(a family of cysteine aspartic acid-specific proteases that
dismantle the cell during the execution or effector stage of
apoptosis; Cryns and Yuan, 1998; Thornberry and Lazebnik,
1998). These observations have since been extended to a
second antiapoptotic Bcl-2 family member, Bcl-xL (Ju¨rgens-
meier et al., 1998). In contrast, both Bax and truncated Bid
cause a rapid destabilization of mitochondria and release of
cytochrome c followed by caspase activation in both intact
cells and cell-free assays (Ju¨rgensmeier et al., 1998; Li et al.,
1998; Luo et al., 1998; Gross et al., 1999).
The exact role of cytochrome c in caspase activation,
owever, remained elusive until the purification and clon-
ng of a protein termed Apaf-1 (Zou et al., 1997), isolated as
art of a trimeric protein complex that could reconstitute
rocaspase processing and apoptotic events in cell-free
ssays (hence, the original names given to these proteins
ere apoptotic protease-activating factors or Apaf-1, -2, and
3). The other two proteins of this complex were identified
s cytochrome c (Apaf-2) and caspase-9 (Apaf-3) (Li et al.,
997; Zou et al., 1997). Using a number of biochemical
pproaches, Wang and co-workers methodically dissected
he actions and interactions of each component of the Apaf
Copyright © 1999 by Academic Press. All rightrimer in caspase activation. Their results, combined with
dditional new data from other laboratories, have served as
he basis for the following model of apoptosis execution
Green, 1998; Green and Reed, 1998). Release of cyto-
hrome c from mitochondria, an event directly regulated by
cl-2 family members, produces a conformational change in
paf-1, allowing for heterodimeric interaction of the pro-
ein with procaspase-9. The resulting interaction generates
rocaspase-9 oligomers, leading to auto- or transcatalytic
rocessing of the precursor enzyme to fully functional
aspase-9 (Srinivasula et al., 1998). Once activated,
aspase-9 then initiates a proteolytic cascade by sequential
ctivation of other death effector caspases, most notably
aspase-3 (Green, 1998).
This model is important for two reasons. First, it provides
he critical communication bridge between stage 3 (regula-
ors) and stage 4 (effectors) of apoptosis (Fig. 2). Second, the
loning of Apaf-1 revealed evolutionary conservation with a
ey proapoptotic molecule in C. elegans, termed CED-4
Hengartner, 1996; Metzstein et al., 1998), that functions
ownstream of CED-9 to activate a cysteine protease re-
erred to as CED-3 (Fig. 3). Functional inactivation of CED-4
r CED-3 in C. elegans results in survival of the 131
omatic cells normally destined for deletion during devel-
pment (Hengartner, 1996; Metzstein et al., 1998), arguing
hat these two proteins are indeed required for programmed
ell death in the nematode. Moreover, the ced-3 gene
roduct represents the fourth example discussed herein of a
rotein whose structure and cell death-regulatory function
ave been conserved through evolution based on its striking
tructural and functional similarities with a caspase ho-
olog in Drosophila (Song et al., 1997) and caspases in
ertebrates (Cryns and Yuan, 1998; Thornberry and Lazeb-
ik, 1998). Therefore, analogous to the linear functional
elationship between CED-9, CED-4, and CED-3 in regulat-
ng cell death in C. elegans, Apaf-1 couples Bcl-2 protein
amily function (regulation of mitochondrial cytochrome c
elease) to caspase function (processing of procaspase-9 and
ctivation of death effector caspases) in the apoptotic cell
eath program in vertebrates (Fig. 3). Of final note in this
ection, another putative vertebrate CED-4 homolog,
ermed FLASH, has recently been cloned and appears to
unction specifically in the Fas-mediated pathway of
poptosis (Imai et al., 1999). While the functional role of
LASH in various paradigms of apoptosis in the body
emains to be established, these data nonetheless indicate
hat, like the existence of multiple CED-9 and CED-3
omologs identified in chordates to date, there will be a
rowing family of CED-4 homologous proteins in verte-
rates as well.
PRENATAL FEMALE GERM CELL DEATH:
THE HOURGLASS IS INVERTEDIn the mouse embryo, primordial germ cells (PGC) of
both sexes can be first identified posterior to the primitive
s of reproduction in any form reserved.
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5Oocyte Apoptosisstreak on day 7.5 of gestation (e7.5). After migration from
the allantois through the developing hindgut mesentery to
the developing genital ridges, the PGC initiate their devel-
opmental programs of oogenesis or spermatogenesis (Eddy
et al., 1981; Ginsburg et al., 1990; Wylie, 1999). Similar
patterns of PGC development and migration have been
identified in many animal species, including the chick
(Fujimoto et al., 1976) and Drosophila (Warrior, 1994), and
considerable research effort has been expended to elucidate
the control of PGC survival during these early stages of
embryogenesis. However, with the focus of this review
being oocyte death, the reader is referred elsewhere for
discussions of PGC fate (Buehr, 1997; Pesce et al., 1997;
Tilly, 1998b).
Most of the research efforts directed at understanding the
occurrence and regulation of oocyte apoptosis have been
conducted with vertebrate model systems, and thus it is on
chordates that this review will primarily focus. However,
two recent reports, one from work in Drosophila (McCall
nd Steller, 1998) and another from studies of C. elegans
Gumienny et al., 1999), offer potential new models to
xplore the genetics of cell death during invertebrate oogen-
sis and thus will be commented on in detail later in this
rticle. In the developing mouse fetus, PGC that have
olonized the developing ovaries (the germ cells are now
eferred to as oogonia) continue to proliferate and thus
xpand the female germline. Peak numbers of germ cells are
eached by around e13.5, at which time many of the
ogonia have left the mitotic cell cycle and initiated the
rst steps of meiosis (Byskov, 1986). After passing through
he leptotene, zygotene, pachytene, and diplotene stages of
eiosis I, the oocytes become arrested in diakinesis coin-
ident with their enclosure by a specialized population of
omatic (pregranulosa) cells to form primordial follicles
Byskov, 1986). An identical situation is believed to proceed
n human fetal ovaries (Briggs et al., 1999), with peak germ
ell numbers of around 7 3 106 reached by approximately
the 20th week of gestation (Baker, 1963; Tilly and Ratts,
1996).
However, in all vertebrate species examined to date,
females are born with far fewer oocytes than the peak
numbers present during early oogenesis. In fact, it has been
estimated that over two-thirds of the potential female germ
cell pool is lost by the time of birth in rats (Beaumont and
Mandl, 1961), mice (Borum, 1961; Bakken and McClana-
han, 1978), and humans (Pinkerton et al., 1961; Baker, 1963;
Forabosco et al., 1991), resulting from attrition of both
oogonia and oocytes (Borum, 1961; Bakken and McClana-
han, 1978). Using a wide variety of techniques, including
morphological assessments (Pesce and De Felici, 1994; De
Pol et al., 1997; Morita et al., 1999a), fluorescence-activated
cell sorting (Coucouvanis et al., 1993), and DNA fragmen-
tation assays (Ratts et al., 1995; De Pol et al., 1997; Morita
et al., 1999a), several laboratories have independently con-
firmed the involvement of apoptosis in this paradigm of
developmental cell death. Therefore, it can be argued that
aging of the ovary (in effect, ticking of the female biological
Copyright © 1999 by Academic Press. All rightclock), if defined by germ cell depletion via a physiological
death process, begins even before the animal is born (Fig. 1).
ENDOCRINE-REGULATED CELL DEATH
DURING OOGENESIS: DEFINING THE
SIZE OF THE UPPER RESERVOIR
Early genetic analyses (Mintz and Russell, 1957) revealed
gonadal dysgenesis and sterility in male and female mice
that lack functional expression of stem cell factor (SCF, also
referred to as the Steel locus gene product) or its receptor,
c-kit (also referred to as the W or dominant white-spotting
locus gene product). These observations support a number
of subsequent reports that SCF, acting via c-kit, is a primary
growth and survival factor for murine PGC (De Felici and
Dolci, 1991; Matsui et al., 1991; Dolci et al., 1993; Pesce et
al., 1993) and oocytes (Packer et al., 1994; Morita et al.,
1999a). However, SCF is probably only one of many endo-
crine factors involved in regulating germ cell fate during
female gonadal development. For example, leukemia in-
hibitory factor (LIF) has been identified as a potent survival
factor for murine PGC (De Felici and Dolci, 1991; Matsui et
al., 1991; Dolci et al., 1993; Pesce et al., 1993) and a critical
component needed for the antiapoptotic benefits provided
by SCF in the fetal ovarian germ cell pool (Morita et al.,
1999a). These in vitro culture observations are, however,
not supported by genetic evidence since knockout of LIF
does not result in impaired gonadal development or fertility
problems in mice of either sex, albeit subtle uterine defects
related to implantation failure were occasionaly seen in
female mice (Stewart et al., 1992). It may be that ligand
activation of gp130, the high-affinity receptor for LIF, is
accomplished in LIF-null (and, perhaps, wild-type) mice
through other factors, such as oncostatin M, that are known
to also bind gp130 and thus mimic the actions of LIF on
PGC (Koshimizu et al., 1996; Hara et al., 1998). These
findings, taken with additional data that indicate roles for
interleukin-4 (PGC, Cooke et al., 1996), basic fibroblast
growth factor (PGC, Matsui et al., 1992), tumor necrosis
factor-a (PGC, Kawase et al., 1994), Gas 6 (PGC, Matsubara
et al., 1996), insulin-like growth factor-I (IGF-I) (oogonia/
oocytes, Morita et al., 1999a), retinoic acid (PGC, Ko-
shimizu et al., 1995; oogonia/oocytes, Morita and Tilly,
1999), and transforming growth factor-b (PGC, Godin and
Wylie, 1991; oogonia/oocytes, Morita et al., 1999a) in
gametogenesis as well, suggest that the endocrine control of
oogonium and oocyte fate during fetal ovarian development
is likely to be extremely complex (Fig. 4).
Very little is currently known of the intracellular effec-
tors utilized by the ligand-activated hormone receptors that
provide anti- or proapoptotic signals in germ cells. In many
somatic cell lineages, survival factor-promoted activation
of phosphatidylinositol 39-kinase (PI3K) appears to be criti-
cal for the suppression of apoptosis (for examples, see
Franke et al., 1995; Yao and Cooper, 1995; Kennedy et al.,
1997; Kulik et al., 1997). One likely downstream candidate
s of reproduction in any form reserved.
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6 Morita and Tillyfor PI3K-mediated phosphorylation is the serine–threonine
kinase c-Akt, an enzyme thought to directly couple cyto-
kine signaling to the Bcl-2 family of proteins (reviewed in
Gajewski and Thompson, 1996; Franke and Cantley, 1997;
Kulik et al., 1997) as well as to the death effector caspase
cascade (Cardone et al., 1998). In agreement with these
studies, pharmacologic inhibition of PI3K has been reported
to abolish the antiapoptotic actions of SCF, LIF, and IGF-I in
FIG. 4. Hypothetical intracellular map of the regulatory process
etails and pertinent references). During murine fetal ovarian deve
any extracellular stimuli, including survival factors (e.g., SCF, LIF
GFb). Survival factors utilize, among other messengers, phospha
c-Akt phosphorylation and activation. In addition, based on recen
ositive effects on ceramidase activity to generate the pro-survival
he absence of adequate survival factor support, intracellular deat
ay prevail to activate apoptosis. Whatever the initiating stimul
cl-w, Bcl-xL, Mtd/Bok, Bax) is probably central to the final decis
execution. If apoptosis is the outcome, mitochondrial cytochrom
oligomerization. Note that the ability of RA to promote mitosis via
arrows and text). Survival pathways are highlighted by blue arrows agonocytes of cultured fetal mouse ovaries (Morita et al.,
1999a). Interestingly, however, the effects of RA on oogo-
Copyright © 1999 by Academic Press. All rightium and oocyte survival are not altered by PI3K inhibitors,
uggesting the existence of multiple intracellular pathways
esponsible for transducing survival signals within the
eveloping germline (Fig. 4). The actions of RA on the fetal
vary are somewhat more complex to decipher than cyto-
ine regulation since, unlike SCF, LIF, and IGF-I, which act
rincipally as antiapoptotic factors (Morita et al., 1999a),
RA promotes both survival and proliferation of developing
at determine the fate of the mouse female germline (see text for
ent, the survival or death of oogonia and oocytes is modulated by
-I, interleukin-1b (IL1b)), retinoic acid (RA), and death factors (e.g.,
inositol 39-kinase (PI3K) to prevent apoptosis, possibly involving
servations (Nikolova-Karakashian et al., 1997), IL1b may act via
cule, sphingosine 1-phosphate (S1P), from ceramide substrates. In
nals such as acid sphingomyelinase (ASMase)-generated ceramide
ignaling into mitochondria via Bcl-2 family members (e.g., Bcl-2,
made by the female germ cell to commit to or repress apoptosis
cyt-c) release likely triggers the caspase cascade through Apaf-1
ation of retinoic acid receptors (RAR) is restricted to oogonia (black
xt, whereas death pathways are highlighted by red arrows and text.es th
lopm
, IGF
tidyl
t ob
mole
h sig
us, s
ion
e c (female gonocytes (Morita and Tilly, 1999). The mitogenic
response of oogonia to RA requires de novo gene expression,
s of reproduction in any form reserved.
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7Oocyte Apoptosismost likely mediated via nuclear translocation of ligand-
activated retinoic acid receptors (RAR) known to be ex-
pressed in the developing female germline, whereas the
antiapoptotic effects of RA proceed completely independent
of new macromolecular synthesis (Morita and Tilly, 1999).
Future studies of mice lacking functional expression of RA
receptors and binding proteins, such as the RAR-a (Lufkin
t al., 1993) and retinoid X receptor-b (Kastner et al., 1996)
nockouts, which are already known to exhibit defects in
permatogenesis, may provide important genetic clarifica-
ion of the mechanisms by which RA exerts its multifac-
ted actions within the female germline (Fig. 4).
INTEGRATION OF THE OOCYTE DEATH
SIGNAL: THE BCL-2 FAMILY AS A
STOPCOCK
The first clue that Bcl-2, the founding member of this
large family of anti- and proapoptotic molecules, functions
in female germ cells was provided by a histomorphometric
evaluation of ovaries collected from young adult bcl-2 gene
knockout mice (Ratts et al., 1995). Mutant females were
found to possess a significantly reduced number of oocyte-
containing primordial follicles compared with age-matched
wild-type female mice, suggesting that Bcl-2 is at least one
contributing piece to the puzzle of female germ cell death.
This conclusion is consistent with the fact that significant
amounts of Bcl-2 protein can be detected in e12.5 and e15.5
female mouse germ cells following in vitro culture without
r with SCF (Pesce et al., 1997) and that polyadenylated
bcl-2 mRNA transcripts are present in developing oocytes
of the postnatal murine ovary (Jurisicova et al., 1998).
onetheless, it remained to be determined if Bcl-2 could
irectly repress apoptosis in the female germline. This
ostulate was recently confirmed in studies of female mice
ith targeted expression of human Bcl-2 only in oocytes
hat revealed marked resistance of transgenic oocytes to
aturally occurring and toxicant-induced apoptosis (Morita
t al., 1999b).
Further evidence that Bcl-2 family members function as
ey determinants of germ cell fate is derived from studies of
nforced expression of a second antiapoptotic molecule,
cl-xL, in PGC collected from e11.5 mouse gonads (Wa-
anabe et al., 1997). Despite the fact that mouse gonads are
ot distinguishable as male versus female at this stage of
mbryogenesis (and thus, no conclusions are drawn about
emale germ cells per se), the data clearly show that loss of
GC in culture can be retarded by transfection with bcl-xL
(or a viral antiapoptotic gene homologous to bcl-2 termed
E1B-19K). Based on the reportedly high levels of polyade-
nylated bcl-x mRNA transcripts in murine oocytes (Jurisi-
ova et al., 1998), it is quite likely that, like PGC, Bcl-xL
functions in the molecular program of oocyte survival.
Unfortunately, mice possessing a targeted disruption of the
bcl-x gene die very early in fetal development (Motoyama et
l., 1995), and thus some type of conditional knockout of
c
d
Copyright © 1999 by Academic Press. All righthe bcl-x gene in only the germline will be required to
directly test the requirement of Bcl-xL in regulating oocyte
ate. More recent investigations derived from analysis of
ax-mutant (2/2) female mice have provided the first clues
hat proapoptotic members of the Bcl-2 family are function-
lly important in oocytes as well (Perez et al., 1997, 1999a);
owever, since the defects in oocyte apoptosis conveyed by
ax-deficiency appear to be most prominent in postnatal
ife, these discussions will be expanded below (see “Postna-
al Oocyte Loss” and “Premature Ovarian Failure”). Little
lse is currently known of the function of other Bcl-2 family
embers in oocyte demise. However, based on findings
hat murine oocytes possess polyadenylated bcl-w mRNA
ranscripts (Jurisicova et al., 1998), ongoing analysis of
varies from bcl-w-null female mice may prove informative
Robles et al., 1999a), particularly in light of the failed
gametogenesis reported in Bcl-w-deficient males (Ross et
al., 1998; Print et al., 1998).
Before concluding this section, it is important to also
note that a very recent series of elegant genetic studies of
cell death during oogenesis in C. elegans has provided
important clues as to the evolutionary conservation of the
factors responsible for determining oocyte fate (Gumienny
et al., 1999). Interestingly, CED-9 loss of function was
found to cause massive programmed death in the germline,
consistent with the reported requirement for CED-9 in C.
elegans somatic cell survival (Hengartner, 1996; Metzstein
et al., 1998). By comparison, oogenesis was unaffected in
Egl-1 mutants (Gumienny et al., 1999), dramatically con-
trasting the excessive somatic cell survival noted in Egl-1-
deficient worms (Conradt and Horvitz, 1998). Therefore,
naturally occurring developmental cell death during oogen-
esis may be more acutely regulated by the actions of
antiapoptotic (CED-9 in C. elegans; Bcl-2, Bcl-w, or Bcl-xL
in vertebrates), as opposed to proapoptotic (Egl-1 in C.
legans; Bax in vertebrates), molecules that comprise this
entral integration step in cell death signaling (Figs. 2
nd 3).
EXECUTION OF OOCYTE DEATH: THE
GRAIN OF SAND IS LOST FOREVER
As discussed earlier, caspases are considered primary
executioners of apoptosis in diverse cell lineages and ani-
mal species (Thornberry and Lazebnik, 1998). Not surpris-
ingly, several caspase family members are known to be
expressed in murine oocytes (Bergeron et al., 1998; Jurisi-
ova et al., 1998). From a genetic perspective, excess num-
ers of oocyte-containing primordial follicles are endowed
n the ovaries of neonatal caspase-2-deficient female mice
Bergeron et al., 1998), suggesting that at least this specific
amily member plays a prominent role in the effector stage
f oocyte demise during development. In agreement with
his, recent preliminary evidence generated from studies of
ultured fetal mouse ovaries indicates that the time-
ependent occurrence of germ cell apoptosis initiated by
s of reproduction in any form reserved.
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8 Morita and Tillyserum starvation in vitro can be abrogated by inclusion of
eptide inhibitors of caspases (zVAD-fmk, zDEVD-fmk) in
he culture medium (Morita et al., 1999c). Moreover, single-
ell caspase activity assays, which rely on cleavage of
uorescent molecules from a specific caspase substrate that
an be preloaded into cells, have confirmed activation of
aspases in oogonia and oocytes of cultured fetal mouse
varies during apoptosis (Morita et al., 1999c). Unfortu-
ately, little else is known of the role played by other
aspase family members in germ cell death during verte-
rate oogenesis, although the recent generation of addi-
ional caspase family member knockouts (for examples, see
uida et al., 1996, 1998) should provide valuable new
enetic tools to answer these questions.
It is noteworthy that in Drosophila, a caspase homolog
ermed DCP-1 has been implicated in normal nurse cell
unction required for oogenesis (McCall and Steller, 1998).
n each ovarian egg chamber of the fly, 15 germline-derived
urse cells are connected to each other and to a single
ocyte via cytoplasmic bridges. During development of the
gg, DCP-1-dependent death of the nurse cells, which
ransfer RNA, protein, and mitochondria to the oocyte just
rior to their demise, must occur for the final steps of
ogenesis to proceed (McCall and Steller, 1998). This para-
igm of programmed cell death, in which one population of
ermline-derived cells commits to apoptosis for the benefit
f a single sister germline cell, underscores the significant
nd evolutionarily conserved role of caspases in oocyte
evelopment. This concept is further exemplified by recent
ork in C. elegans in which mutant worms lacking expres-
sion of CED-3, the C. elegans counterpart to caspases in
vertebrates, exhibit reduced oocyte death during oogenesis
(Gumienny et al., 1999). Therefore, future genetic studies
with these invertebrate model systems, as well as with
genetic-null mouse models, should continue to unravel the
mysteries of cell death in the female germline and establish
what will likely be a blueprint for oocyte death conserved
remarkably through evolution (Fig. 4).
OOCYTE LOSS DURING POSTNATAL
LIFE: THE CLOCK KEEPS TICKING
Survival of oocytes is a continuous battle, carried forward
from the earliest stages of fetal ovarian development (see
above) throughout adult life. As mentioned earlier, human
females are provided with approximately 1 3 106 oocytes at
birth, a starting reserve that is further decimated by
apoptosis to fewer than 4 3 105 by puberty and to fewer
than 1 3 103 in the years immediately preceding ovarian
senescence (on average, around age 50) (Richardson et al.,
1987; Faddy et al., 1992; Wise et al., 1996). Considering that
a woman will generally ovulate a single egg during each
monthly cycle, at most only 400 or so oocytes survive and
advance to the point of ovulation in adult life. A quick
calculation thus reveals that greater than 99.9% of the
Copyright © 1999 by Academic Press. All rightocytes endowed in the human ovaries at birth face death as
heir ultimate fate, a process which, when completed, leads
o exhaustion of the follicle reserve and the menopause (Fig.
). Discussions of postnatal oocyte loss in mammals, how-
ver, become somewhat more complicated since the pro-
ess of germ cell depletion, referred to as follicular atresia,
an be initiated as a direct consequence of oocyte apoptosis
r as an indirect consequence of apoptosis of the supporting
omatic (granulosa) cells that nourish and mature the
ocyte throughout postnatal life. The latter instance of
erm cell loss occurs in follicles that have already pro-
ressed through several developmental stages and thus can
e considered atresia of maturing (late preantral to early
ntral) or fully ripened (preovulatory) follicles. Since this
aradigm of ovarian cell turnover is primarily somatic in
ature, the reader is referred elsewhere for comprehensive
eviews of granulosa cell apoptosis during follicular atresia
Tilly, 1996, 1998b; Tilly and Robles, 1999).
In the case of postnatal oocyte loss driven by intrinsic
eath mechanisms within the germ cell itself, in mammals
his is observed in follicles of the quiescent primordial
tockpile and at the earliest stages of development (i.e.,
rimary, small preantral). Although these immature fol-
icles also possess granulosa cells intimately associated
ith the oocyte, it is death of the oocyte (Fig. 5), as opposed
o the somatic cells, that triggers atretic degeneration and
rreversible elimination of the follicle from the ovary
Baker, 1963; Gougeon, 1996; Perez et al., 1999a). Addition-
lly, the negative impact of this paradigm of oocyte death
n the female biological clock may actually worsen with
ge based on a number of observations in women that the
ate of follicle atresia is accelerated in the years preceding
he menopause (Richardson et al., 1987; Faddy et al., 1992).
Unfortunately, due to the technical difficulty in obtaining
sufficient numbers of these populations of follicles for
in-depth analysis, very little is known of the mechanisms
responsible for initiating and executing apoptosis in oocytes
of immature follicles. A single report has, however, offered
the first and very exciting insights into this process and has
provided the only example to our knowledge of a “slowing”
of the female biological clock.
The culprit for these studies is the proapoptotic molecule
Bax (Oltvai et al., 1993), known to be expressed in both
oocytes and somatic granulosa cells of the mammalian
ovary (Tilly et al., 1995; Jurisicova et al., 1998; Kugu et al.,
1998). Although the first report of the creation of Bax-
deficient mice indicated from histological assessments ab-
errant death of ovarian granulosa cells in females (Knudson
et al., 1995), further scrutiny of the ovaries of these animals
revealed that the primordial follicle stockpile is enlarged
threefold by around the time of puberty (Perez et al., 1999a).
These findings were somewhat of a puzzle since additional
histomorphometric evaluations indicated that the oocyte
reserve endowed at birth is identical in wild-type and
knockout females. Only upon careful examination of the
health status of the oocytes within the immature follicle
pool was the basis for the surfeit of primordial follicles in
s of reproduction in any form reserved.
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reduction in the incidence of oocyte apoptosis and imma-
ture follicle atresia (Perez et al., 1999a). Aside from provid-
ng the first proof that postnatal oocyte loss associated with
tresia is genetically programmed, this report established
nother precedent in that the mouse equivalent of the
enopause was delayed. In fact, bax-mutant female mice at
2 months of age, somewhere roughly equivalent to a
00-year-old woman, still retained hundreds of follicles at
ll developmental stages, including those responsible for
strogen biosynthesis (Perez et al., 1999a). Therefore, future
tudies that concentrate on atresia of immature follicles in
he postnatal mammalian ovary, including analyses of
ther genetic-null mouse lines lacking expression of key
poptosis-regulatory molecules, are certainly needed to
FIG. 5. Morphology of murine oocyte demise in vivo during po
(primordial, primary, small preantral) follicles is driven by the indu
in the follicle on the left (arrow) compared with the healthy oocyte
permission (Nature America) from Perez et al. (1999a).ully understand what makes the female biological clock
ick.
Copyright © 1999 by Academic Press. All rightSPONTANEOUS OOCYTE
FRAGMENTATION IN VITRO: IS IT
OR IS IT NOT APOPTOSIS?
The final paradigm of “natural” oocyte demise to be
discussed before finishing with an example of pathologic
germ cell death is the fate of the small proportion of eggs
that beat the odds by surviving to complete their develop-
mental program of growth, maturation, and ovulation only
to find there is no male gamete waiting to initiate fertiliza-
tion and embryogenesis. Scant data exist on the fate of
ovulated eggs, in vivo, that are not fertilized; however, in all
likelihood these cells simply degenerate in the reproductive
tract and disappear without incident over time. Some
al life. Once endowed in the ovary at birth, atresia of immature
n of oocyte apoptosis, exemplified here by the fragmenting oocyte
he follicle on the right (asterisk). This figure was reproduced withstnat
ctioinsight into this phenomenon may be derived from assess-
ing the consequences of maintaining isolated mature oo-
s of reproduction in any form reserved.
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10 Morita and Tillycytes ex vivo. One of the first reports on this topic was
provided by Takase et al. (1995) who concluded that
poptosis, as defined by both morphological criteria and in
situ analysis of DNA cleavage, is the mechanism respon-
sible for degeneration of unfertilized murine oocytes cul-
tured in vitro. This general observation, and the overall
conclusion, were followed in succession by similar experi-
mental findings from other laboratories (Fujino et al., 1996;
erez and Tilly, 1997).
However, the idea that apoptosis is the mechanism by
hich ex vivo oocyte fragmentation is mediated was then
challenged by a series of studies that failed to show any
correlation between two reported biochemical markers of
FIG. 6. Morphological and biochemical features of murine oocyte
from anticancer drug treatment, initiate a series of events consisten
budding and fragmentation (B), caspase activation as assessed by c
fluorescence), and DNA cleavage as detected by 39-end labeling o
fluorescence). By comparison, intact oocytes do not exhibit any of
and then reproduced with permission (Oxford University Press) froapoptosis (DNA cleavage and phosphatidylserine exposure
on the outer leaflet of the plasma membrane) and fragmen-
Copyright © 1999 by Academic Press. All righttation of murine or human oocytes in vitro (Van Blerkom
and Davis, 1998). The reasons for this discrepancy remain
to be resolved. However, a detailed follow-up investigation,
reaffirming that unfertilized murine oocytes maintained in
vitro do in fact initiate a series of morphological and
biochemical changes consistent with the occurrence of
apoptosis, including cytoplasmic condensation, membrane
budding, caspase activation, and DNA fragmentation (Fig.
6), offers some possible explanations (Perez et al., 1999b).
Among these, it was stressed that diverse cell types appear
to undergo apoptosis in subtly different ways. Therefore,
scientists wishing to study apoptosis should consider, at
least at the onset of such investigations, the use of several
in vitro. Oocytes dying in vitro, either spontaneously or resulting
h the occurrence of apoptosis. These include cellular condensation,
ge of rhodamine from a caspase substrate peptide (D, intense red
A fragments with fluorescent deoxynucleotides (F, intense green
features (A, C, and E, respectively). These data were reconfigured
erez et al. (1999b).death
t wit
leava
f DNdifferent assays to detect apoptosis since not all morpho-
logical or biochemical features may be displayed by a given
s of reproduction in any form reserved.
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11Oocyte Apoptosiscell undergoing this form of death. In addition, the recent
demonstration that spontaneous oocyte fragmentation in
itro is inhibited by overexpression of a classic antiapop-
otic molecule (i.e., Bcl-2; Morita et al., 1999b) further
upports the hypothesis that this paradigm of oocyte de-
ise is indeed apoptosis.
PREMATURE OVARIAN FAILURE: THE
STOPCOCK IS FURTHER LOOSENED
Up to this point, essentially all of the discussions have
focused on the events surrounding normal oocyte loss via
apoptosis in the context of either fetal or postnatal ovarian
development. However, as hinted at in the Introduction and
as indicated in Fig. 2, apoptosis can be initiated by patho-
logical insults as well. This is of critical importance in the
context of oocyte depletion since the rate at which the
female biological clock ticks can be dramatically acceler-
ated by exposure of the ovaries to noxious agents (Tilly,
1998a). For example, subfertility, if not sterility, and pre-
mature menopause are known to occur in young girls and
reproductive-age women following treatment for cancer
with either chemicals or radiation (Waxman, 1983; Famil-
iari et al., 1993; Reichman and Green, 1994; Ried and Jaffe,
1994; Tilly and Johnson, 1999). Although one can deduce
from the discussions above that the female germline takes
the brunt of this unfortunate side effect of cancer therapy,
only recently has the issue of inappropriate oocyte apopto-
sis been directly tested as a potential mechanism. Using
female mice as an experimental model (since female mice,
like women, are known to respond to chemotherapeutic
drugs with oocyte toxicity and ovarian failure; Takizawa et
al., 1989; Shima, 1994), it was shown that oocytes exposed
either in vivo or in vitro to the classic chemotherapeutic
drug, doxorubicin (Adriamycin, 14-hydroxydaunomycin),
undergo apoptosis (Perez et al., 1997).
Of greater significance, several discrete apoptosis-
regulatory molecules have been identified as necessary for
murine oocyte death initiated by chemotherapy, while
others were found to be dispensable. For example, culture of
oocytes with sphingosine 1-phosphate, a naturally occur-
ring metabolite of ceramide and inhibitor of ceramide-
promoted stress kinase activation and apoptosis (Cuvillier
et al., 1996; Spiegel et al., 1998), antagonizes oocyte
apoptosis induced by doxorubicin (Perez et al., 1997). These
findings, which imply a functional role for ceramide as an
early proapoptotic signal generated in oocytes by anti-
cancer drug exposure, are in agreement with the reported
function of ceramide as a mediator of daunomycin-induced
tumor cell death (Bose et al., 1995; Jaffrezou et al., 1996). It
is hoped that current efforts to explore the impact of
knocking out acid sphingomyelinase (Horinouchi et al.,
1995), a hydrolytic enzyme responsible for ceramide gen-
eration from plasma membrane lipids (Kolesnick and
Kronke, 1998), on chemotherapy-induced ovarian failure in
female mice (Y. Morita, G. I. Perez, S. Miranda, D. Ehleiter,
Copyright © 1999 by Academic Press. All rightE. H. Schuchman, R. N. Kolesnick, and J. L. Tilly, unpub-
lished observations) will provide important genetic confir-
mation of data obtained with sphingosine 1-phosphate-
mediated inhibition of germ cell death. By comparison,
oocytes obtained from female mice harboring a targeted
disruption in the gene encoding a second primary signaling
molecule known to be associated with cell death induction,
namely p53, are as sensitive to doxorubicin-induced
apoptosis as their wild-type counterparts (Perez et al.,
1997). These observations starkly contrast the reported
requirement for p53 in various paradigms of tumor cell
death induced by antineoplastic drugs (Ding and Fisher,
1998), underscoring the fact that various cell lineages, even
responding to the same stimulus, can and do use a variety of
early signaling molecules to accomplish the same goal, i.e.,
the activation of apoptosis.
Once the death signal has been propagated in murine
oocytes by chemotherapy, it clearly appears to funnel
through Bax as a central integrator since Bax-deficient
oocytes are resistant to apoptosis induced by doxorubicin,
both in vivo and in vitro (Perez et al., 1997). These obser-
vations are key for two reasons: first, the pathways govern-
ing oocyte fate during development appear to also function
as primary determinants of germ cell death following patho-
logic insults, and second, targeting Bax for inactivation in
oocytes may provide a novel approach to overcoming ovar-
ian failure in female cancer patients. Regarding the latter,
recent efforts to target expression of the Bax-neutralizing
molecule, Bcl-2, only in oocytes have confirmed that this
technology is indeed feasible and that oocyte-specific pro-
tection from chemotherapy-induced destruction can be
achieved, at least in female mice (Morita et al., 1999b).
Finally, and perhaps as expected based on molecular
ordering studies of cell death-regulatory molecules in other
systems, caspases appear to function as the death effector
molecules in chemotherapy-induced germ cell destruction.
Evidence for this comes from three sets of experiments, the
first of which employed specific and irreversible small
peptide inhibitors of caspases to prevent doxorubicin-
initiated oocyte fragmentation in vitro (Perez et al., 1997).
Although these peptide inhibitors show wide cross-
reactivity with many different caspases, a subsequent as-
sessment of the apoptotic response in caspase-2-deficient
oocytes following chemotherapy exposure confirmed that
at least this one family member is central to germ cell
demise (Bergeron et al., 1998). The third piece of evidence
indicting caspases as executioners of oocytes comes from a
very recent series of single-cell caspase activity assays
which revealed that caspases are indeed activated in oo-
cytes prior to the cascade of morphological changes associ-
ated with apoptotic death (Perez et al., 1999b) (Fig. 6). These
final observations are in agreement with the reported role of
caspases in cleaving specific molecules to produce many of
the biochemical and morphological features of apoptotic
cell death (Cryns and Yuan, 1998; Thornberry and Lazeb-
nik, 1998) and therefore help establish in oocytes a tempo-
ral framework of events leading to apoptosis.
s of reproduction in any form reserved.
1
1
f
s
b
(
e
d
p
n
p
c
c
o
b
t
w
s
q
w
o
a
o
o
b
s
w
t
t
f
m
f
a
c
r
d
l
1
d
r
r
m
a
s
s
p
t
c
a
b
s
h
f
f
f
t
c
s
i
w
w
(
m
e
a
h
d
12 Morita and TillyCONCLUDING REMARKS AND FUTURE
DIRECTIONS
Although considered by many to be an immutable law of
nature, the incessant ticking of the female biological clock
may, based on the studies discussed above, actually be
amenable to manipulation with dramatic consequences for
extending ovarian life span and maintaining fertility under
conditions not normally conducive to such outcomes. De-
spite the exciting progress made over the just the past few
years in understanding not only the occurrence and conse-
quences of apoptosis in the female germline but the genetic
regulation of the phenomenon, there remain many unan-
swered questions that will serve as ripe seeds for future
research harvesting and application. For example, why do so
may germ cells die off in females before birth? Hypotheses
ranging from inadequate survival factor support from sur-
rounding somatic cell lineages (Tilly, 1996; Pesce et al.,
997) to abnormalities in meiotic pairing events (Speed,
988; Mittwoch and Mahadevaiah, 1992) have been put
orth to explain the basis of prenatal oocyte death. Some
urprises have surfaced as well, with one notable example
eing the impact of knocking out the ataxia–telangiectasia
AT-mutated or ATM) gene on gametogenesis. Believed to
ncode a protein principally involved in the cellular DNA
amage response, such as that elicited by radiation (West-
hal, 1997; Taylor, 1998), ATM-deficient mice show post-
atal sterility due to massive apoptosis of germ cells at
rophase I of meiosis (Barlow et al., 1998). Although not
ompletely understood at present, it may be that ATM is
ritical for maintaining survival of germ cells during mei-
tic recombination events that involve DNA strand breaks.
A second intriguing question concerns the relationship
etween oocyte apoptosis and premature ovarian failure,
he latter of which extends far beyond infertility associated
ith cancer treatment since early menopause is known to
trike some women well before the normal time of ovarian
uiescence for as yet unknown reasons. One prediction
ould be that key apoptosis-regulatory genes are aberrantly
verexpressed (proapoptotic genes) or not expressed (anti-
poptotic genes) in female germ cells during ovarian devel-
pment, thus creating a situation in which the starting
ocyte reserve is compromised prior to or from the time of
irth. Of course, accelerated depletion of a normal follicle
tockpile through atresia could also result in inappropriate
astage of oocytes, hastening the time to menopause. With
he accumulating evidence from gene knockout mice iden-
ifying specific apoptosis-regulatory molecules as crucial
or normal germ cell dynamics in the female, future assess-
ents of these genes in the context of premature ovarian
ailure may prove revealing. These studies may be further
ssisted by investigations of other key cell death-
ontrolling genes in germ cells, in particular the possible
ole played by the CED-4 homolog, Apaf-1, in mediating
eath signals within oocytes. The availability of mice
acking expression of functional Apaf-1 (Cecconi et al.,
Copyright © 1999 by Academic Press. All right998; Yoshida et al., 1998), coupled with recent evidence for
evelopmentally regulated expression of Apaf-1 in the mu-
ine ovary (Robles et al., 1999b) and for the functional
equirement for CED-4 in C. elegans germline death (Gu-
ienny et al., 1999), make this particular example an
ttractive possibility for in-depth study.
In conclusion, it is clear that the female germline repre-
ents a relatively new and very dynamic model system for
tudying the actions and interactions of the various com-
onents of a cell death pathway remarkably conserved
hrough evolution. In this review, we sought to provide a
omprehensive evaluation of the literature regarding oocyte
poptosis as a means to explain the molecular and genetic
asis of the female biological clock. Just as each grain of
and passes from the upper to the lower reservoir of an
ourglass, at a rate predetermined by the diameter of the
unnel separating the two compartments, oocytes are lost
rom the ovary at a rate which directly impacts on the
unctional life span of the female gonads. However, unlike
he grains of sand in an hourglass, the data discussed herein
ollectively demonstrate that the rate of oocyte depletion is
ubject to manipulation by many genetic and pharmacolog-
cal approaches. The prospects for controlling the rate at
hich oocytes commit themselves to death are enormous,
ith preserving ovarian function in female cancer patients
Perez et al., 1997; Reynolds, 1999) to delaying the natural
enopause in women (Perez et al., 1999a) offered as prime
xamples. Although more work is certainly needed before
ny clinical application can be considered, we can only
ope that future research progress in the area of oocyte
eath will be swift. After all, the clock is ticking.
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